Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. 2663916. Last updated 14. Forex. . 0¢. I think that the more time that passes without profits, the less likely that there will ever be profits. Disowned him really. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial Review About this app. HotCopper has news, discussion, prices and market data on PROTEOMICS INTERNATIONAL LABORATORIES LTD. . Click for more information. Is this a case of short memories? The best one can say is her surprise is disingenuous. Contacts. Volume. The last time was December 2018. . However, the interim results from ongoing Phase One NCT04865419 (the most advanced trial) was a little underwhelming IMO. In SPL's case there is clearly another. They not even have a license with SPL, just a basic research agreement. It is easy to be a negative poster on here when there has not been anything positive to come out of the company for a looooong time. . While the chart is not good there is a glimmer hope maybe emerging. Share New future tech coming Antibody fragment-nanoparticle therapeutic eradicates cancerPosted YesterdayA multi-institutional team of researchers found novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicating gastric cancer in treated mice. . A correctly formatted example follows: Title of my presentation for the conference. LEADING THE BATTERY METALS REVOLUTION. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. 36pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on SPARC TECHNOLOGIES LIMITED. The borders are now open Look forward to a positive outcome with new partnership agreements permeating from our team networking at ASCO. 3¢. Share It would be silly to be tight on cash. FORTESCUE METALS GROUP LTD. Eight (8) contributors to the HC SPL thread made price predictions (thank. “If humans respond in a similar way, the benefits of treatment. Market . 57. ASX - By Stock. ASX - Day Trading. 3¢. 3¢. 9¢. Join the HotCopper ASX share market forum today for free. Within a post on another SPL thread, sarge17 said: "I wonder what polished horse turd of an announcement we will get from Starpharma in the final days leading up to the AGM. ASX - By Stock. I think this is the start of a trail that may lead somewhere in hopefully SPL offering shareholder clearer explainations and referenced articles / posters etc in announcements being on website and then later being unavaliable is a process across the ASX that has to be stopped. However, just a word of caution before the usual pumping starts by the usual suspects. They are the future as also mentioned regularly by Eric Topol. 8327/7/2021 SPL $1. . 48. 8. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. ASX - General. Advertise on HotCopper. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Forums. Interesting write-up. It’s unlikely to happen, but personally I hope Rob Thomas and Jackie Fairley fall on their sword prior to the AGM. Created with Sketch. 4. 129294. Created with Sketch. Market . Become a member of Australia's largest investment discussion forum. With EOFY selling about to hit us like a freight train, where does everyone think the bottom will be for SPL' shareprice?Unless one of the many promises. ASX - General. See All Discussions. Share Interesting and positive early pre-clinical results. $0. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - By Stock. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. Last updated 15. Created with Sketch. Target our investor community with our. NSX - By Stock. The thread is titled so that it can be found and general enough so as to. No change of interest notification received. Twenty years later it’s 84. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. . 74. Hey, "smart", I concur with your message. Latest Posts. Starpharma is a world leader in the development of new medical products based on its proprietary dendrimer technology and has partnerships with leading global companies, including AstraZeneca, MSD (Merck & Co. . It is now more than ever that SPL needs to communicate with the market and keep everyone informed of any updates, because the radio silence and smoke and mirrors approach is evidently NOT WORKING. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. Last post 1stPrize. To be fair the ASX has made tries on 3 recent contracts to squeeze information from SPL when didn’t want to disclose how immaterial the contracts is. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial ReviewAbout this app. I'd think that SPL will be covering all the bases required for a crack at 505b2, but with the necessary data to pivot to a phase 3 trial if. Created with Sketch. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on MESOBLAST LIMITED. Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no deal/licence forthcoming. 13. ASX - Day Trading SUBMISSION STEPS. It is lengthy but well worth the time. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. Created with Sketch. 0¢. Latest Posts | Join the HotCopper forum today for free, page-1. Forums. 2327/7/2021 CSL $292. 367026. ASX - Day TradingLet's face it SPL is a very small investment for most of the institutions, they work on the basis of having a portfolio of these "penny dreadfuls" and expect some to come good but most to fail. StarPharma Holdings Ltd. 88. ASX - Day TradingI will just put it out there that I have been peeved off about our CEO Jackie Fairley and the performance of SPL for a while now. Commodities. SPL have put a lot of time and energy into Docetaxel and Cabazitaxel over many years but it is Irinotecan that seems to be wining the race, probably benefiting from the accrued knowledge from the Doc and Cab trials. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. The goal of the partnership. SPL has on multipleoccasions used COVID as an excuse for expanded timelines on active trails andto my understanding SPL has also been receiving support from the governmentduring COVID. 14. ASX - General. 2:00 am Eastern Standard Time Australia. 59pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on MESOBLAST LIMITED. Forums. 5¢. 45K. , Inc. Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. Forums. Latest Posts. Volume. Some links within this article worth a scan too. ASX - Day Trading. SPL Price at posting: 44. This will make for sad reading. ASX - By Stock. I no longer regard SPL as an investment-grade stock. 00. Even Pfizer won’t comment on him. . ACCELERATE RESOURCES LIMITED. Advertise on HotCopper. Jackie in the discussion talked about dealing with the tourist industry. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 49M. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Advertise. Created with Sketch. The reason I loaded up in the year post the last agm was because we we falsely told that vivagel would would be launched in Q1. Join the HotCopper ASX share market forum today for free. 0¢. Hey, "smart", I concur with your message. Created with Sketch. This is a charting thread for those interested in the movements of the SPL SP. 615, today the share price rose by 0. PEG-b-pHPMA-lactate: Docetaxel, microtubule inhibitor/hydrolytic linkerwaste of cash by the time spl manage to do anything with nasal spray covid will have a vaccine if there is one thing spl have deomstrated it is an inability to do anything in a timely fashion. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be resolved. ASX - General. ASX - Short Term Trading. 8¢. Starpharma (SPL) Shares in the nano-biotechnology group bucked the falls in the wider market on Monday after it announced a deal with a division of US pharmaceutical giant Ely Lilly to extend the application of its technologies in the animal health area. Join the HotCopper ASX share market forum today for free. Stay informed on the day’s latest market trends and receive exclusive access to HotCopper’s trending analysis with inside stories from TMH to help you make sense of what’s happened and navigate what’s ahead. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. HotCopper has over 250,000 registered members, and more than 200,000 unique visitors every month and a huge 21 million monthly page impressions. ASX - Day Trading. 5¢. More. ASX - Day Trading. ASX - Short Term Trading. Based on SPL's announcements and on reports of the AGM, my opinion is that the tune of the song that SPL sings never changes. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Comments. An expat Indonesian friend did have search for me but didn't find any promotion etc a little while ago. Join the HotCopper ASX share market forum today for free. 0. ASX - By Stock. Friday 26/06/2020 looks like the slide deck is very similar if not identical to last Friday's audio presentation I will be recording audio just in case this audio presentation is differentSPL management team get bad marks for delays all the time but I don’t read anyone citing possible reasons. The news flow coming from SPL of latehas been lackluster at best. SPL. Time flies. I have no problem with the way SPL accessed the market initially but percieved issues over time and this may be one. Looking at the short term, SPL's SP is currently perched above a technical support line at 50 cents. Advertise on HotCopper. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. 0%. Hey, "smart", I concur with your message. . * The Viraleze trial will be completed. ” This, sadly, is not true. 37. Still waiting for you @antibotter to explain why it appears you tried to influence newbies and less experienced investors into thinking that something big was imminent based on a comment in the SPL newsletter. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on PANCONTINENTAL ENERGY NL. However, I think that maybe SPL is occasionally worth a swing trade gamble. ASX - Short Term Trading. Just begin to imagine that all staff on board use Viraleze well before. opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. , page-3. Last updated 15. Merck will fund the research, although Starpharma doesn’t expect the fees to be material, and. Deliver ZERO dividends, a NEGATIVE capital return and depressed share price to shareholders over a 17 year period. 1 Upvote. 0¢ STARPHARMA HOLDINGS LIMITED - Corporate Spotlight . . Hope that SPL starts to deliver on its promises. Latest Posts. 0. SUBMISSION STEPS. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 5. . Just wondering if anyone else took the time to report Starpharma to the ASX as I did? Remember, NOTHING will ever change if CEOs and Directors of public. 6% downward extention down to (0. 40. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial. Created with Sketch. Notice to Sellers of Vapour Products – PST Rate Increase to 20% Page 3 of 3 Need more info? Online: gov. 06B ! Add to my watchlist. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. ASX - Day Trading. Latest Posts. I sold out of my position in SPL at that time precisely because of this. Created with Sketch. 0¢. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. 0¢ Sentiment: None Disclosure: Held LikesThe CEO seemed to exude a certain excitement in her interview with Alan Kholher have never seen her like that it was bubbling underneath every time she spoke about Viralease. 13. Created with Sketch. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . The 407730 is a sound level meter that measures from 40 to 130dB with an accuracy of 2dB. Created with Sketch. Join the HotCopper ASX share market forum today for free. Created with Sketch. Share It is VERY disappointing that a CEO, Chair and company secretary can still throw a Sky and Land logo onto a corporate presentation as an indication of a partnership even though after 6. 68. 45K. It is because SPL has abrogated the marketing role to its distributors. It knows of Viraleze - so its rationale for letting Viraleze meander through regulatory processes with no due haste or intervention is mystifying. Join the HotCopper ASX share market forum today for free. Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. However, just a word of caution before the usual pumping starts by the usual suspects. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . . Share Financial Analysis: "Dr Jackie Fairley, CEO, Starpharma, commented:These very positive results for DEP® cabazitaxel in three common and hard-to-treat cancers demonstrate its therapeutic and commercial value" The phase 2 results look great and certainly demonstrate therapeutic value. 28pm 13/11/2023 ? TMG (ASX) Chart. Market. 12. S. Created with Sketch. 8. IMO they haven't . As always, she is happy to hoover up freebie shares in the grandiose remuneration agreements as well as collect performance bonuses as disclosed in the Annual Report. SPL Price at posting: 14. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Our magic little formula may just be the answer. Target our investor community with our. Your post is very vague in its relationship somehow with spl, but the intent of the constant negative narrative is obvious. Enter the title of your abstract. Feb 28 (Reuters) - Starpharma Holdings Ltd (SPL) : HY REVENUE FROM CONTINUING OPERATIONS DOWN 16% TO A$1. You should withdraw the statement. $0. Think SPL has a valuation of 500mil…based on potential, or just promise. July 31 (Reuters) - Starpharma Holdings Ltd (SPL) : ASTRAZENECA HAS MADE DECISION TO DISCONTINUE DEVELOPMENT OF AZD0466, AFTER AN INTERNAL REVIEW. Created with Sketch. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Hope that SPL starts to deliver on its promises. Forums. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Firstly, I’m a big fan of SPL and proud of all of their achievements to date (even picked up a few more shares the other day). ASX - By Stock. Since September 2020 the. Market Cap $. 0. Discussion. 1 Introduction. 8¢. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. 3. Created with Sketch. Perhaps they will today tomorrow. 9¢. ASX - By Stock. Canadian Dollar. I am not up to date with all brexit stuff let alone othe rcountries like Vietnam , HK and very cautiious about consultants websites and simply govt websites area nightmare to understand and navigate unless it is your speciality. Market . but hey don't take my word for it, see for yourself in the official SPL ASX announcement dated 17th April 2023 You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. DISCOVER THE BATTERY METALS REVOLUTION. The SP must break out of the. 8¢. 8985. Today it closes up 5% on the high of the bar and all we here. 0¢ Sentiment: Hold Disclosure: Held LikesSPL 7013 is already approved for use in the body (via a mucous membrane) and there would seem to be no issue as regards safety. , page-2. 0¢. Last edited by sarge17: 28/11/22. Timeline. Created with Sketch. - 12:30 p. You got to wonder after huge volumes going through last 4 days and the SP reaching new lows. I’ve seen numerous cases across Hotcopper where a shareholder with a large investment will say whatever it takes, over a sustained period of years, even though it may be highly optimistic, knowingly false or misleading, in an attempt to protect their own investment, even at the expense of other less experienced Hotcopper members and investors. I think SPL are very worried on what a potential class action could implicate. 5¢ Sentiment: Sell Disclosure: Not HeldThe one positive sign is that AstraZeneca are continuing to expand site recruitment for both AZD0466 trials. Latest Posts. any other information the entity wishes to notify to ASX about the cessation?The Performance Rights issued under an employee incentive scheme lapsed during the course of the quarter ended 30June 2023 include 519,053 Rights held by KMP, Nigel Baade, and 310,760 Rights held by non-KMPs. Created with Sketch. Share lol @col69 the phrase "in parallel we are continuing discussions with potential commercial partners" is now etched into SPL's manual for any asx announcements or releases to the public. Join the HotCopper ASX share market forum today for free. 6 MILLION HY LOSS FROM CONTINUING OPERATIONS. it certainly is a confidence booster to keep on topping upGood luck with whatever investments you may hold at the moment, and if you’re still in SPL, hopefully it will get a bit of a bounce soon. SPL scientists will no doubt be working on this right now. Cristal therapeutics. News: SPO Spotless Group To Be Removed From Official List Of ASX Ltd At Close Of Trading On 30 Aug. Forums. Release Date: 27/06/22 09:19; Summary: SPL signs expanded DEP research agreement with US Biopharma; Price Sensitive: Yes; Download Document 194. Along with SPL's seemingly better ADC compared to AZ's Enhertu, perhaps Pascal Soriot is wondering if he jumped into bed with the the wrong partner in Daiichi-Sankyo. . I find it alarming the number of column inches in the resolution explanatory notes, extolling their experiences prior to spl, when not one of them has any achievements in the advancement of spl listed. HotCopper is Australia's largest free and independent stock market trading forum for ASX share prices & stock market discussions. Latest Posts. Share In the last year we have seen the resignation of the Head of Research, David Owen and now the Chief Financial Officer, Nigel Baade. Forums. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. Fortescue Metals Group Ltd (Fortescue) is an Australia-based company engaged in iron ore. 3. SPL conducts a "trial" (use that word loosely) in of all places WA !! Yet our commercial hotshots cannot arrange a deal with a WA based company who appear highly capable and connected in getting distribution to sought after sectors like "Allied Health practitioners, the corporate sector and government". Share It is now 2 years and 8 months since CEO Jackie Fairley bought any shares in her own company on-market. Its a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. Starpharma have so far been quite disappointing in the way it has commercialised products The Vivagel condom A dismal failure so far It had been approved. MGU Magnum Mining and Exploration piecing together optimal logistics plan for Buena Vista iron ore projectI don’t hold, but depending on timing with other investments and Starpharma developments I may become a SPL holder again if the SP drops another 10-20%. The recent announcement about Viraleze nasal. 50 or thereabouts. SPL always has tantalising carrots to dangle before the eyes of investors. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. Talk with one of our capital. . " Indeed. New Zealand Dollar. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be. Created with Sketch. We know that they haven't been marketed well but i think BigPharma have had an input. ASX - By Stock. . Only 12 episodes made but so Iconic . Working in a. 30. 06 Sentiment: Buy Disclosure: Held Created with Sketch. Furthermore the shameful and disappointing thing is that some pumpers on this forum were encouraging newbies (even when the SP hit its $2. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . but have sent email to other companies CEO etc too, with some response, but all are dead end reply or will address and get in contact soon. 17112. 1dB.